Mitchell P. Kopin 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 11:18 am Purchase |
2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 1,289 3.100% |
644 (+100.00%) |
Filing |
| 2024-02-06 10:17 am Sale |
2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 644 6.200% |
-272 (-29.66%) |
Filing |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 916 9.400% |
916 (New Position) |
Filing |